摘要
冠状动脉内支架置入术已成为目前冠状动脉粥样硬化治疗的最重要手段之一,支架内涂层药物能抑制平滑肌细胞的生长,降低血栓发生率,但也抑制了内皮细胞的爬行,延迟了再内皮化的进展。如何促进再内皮化已成为关注的焦点,内皮祖细胞的发现和不断的研究进展,为再内皮化打开了一条新道路。
Coronary artery stent implantation has become one of the most important treatment method of coronary atherosclerosis,stent coating drugs can inhibit the growth of smooth muscle cells,reduce the incidence of thrombosis,but also inhibits endothelial cell,delay the progress ofreendothelialization.How to promote the viability and proliferation of endothelial cells,has become the focus of attention,the discovery of endothelial progenitor cells and continuous research opened a new road to re-endothelialization.
出处
《中国当代医药》
2014年第34期191-194,共4页
China Modern Medicine
基金
河南省医学科技攻关计划项目(200903139)
关键词
经皮冠状动脉介入治疗
内皮祖细胞
再内皮化
Percutaneous coronary intervention
Endothelial progenitor cells
Re-endothelialization
